Renal Function Clinical Trial
Official title:
An Estimated Glomerular Filtration Rate (eGFR) Level Prediction
Scientific analyses are frequently performed on e.g. health insurance databases to study the
usage and effectiveness of drugs in real life.
Kidney function is known to have an influence on a patients disease development and/or drug
levels in blood.
However, often direct measures for kidney function are not available in databases.
This study plans to develop tools to classify the renal function of patients, which helps
scientists to identify patient cohorts (groups of patients sharing same characteristics) for
scientific analyses.
Renal impairment is a common comorbidity in patients with diverse main underlying diseases
and a pathology accompanying increasing age. Renal function might be an important modifier of
treatment effects.
Population-based administrative claims databases are increasingly used in large-scale
comparative outcomes studies of drug treatments. However, claims databases often lack
information on laboratory tests results limiting their usefulness in Real-World Evidence(RWE)
research of patients with renal impairment.
There is a need to develop methods for identification of patients with renal dysfunction from
healthcare administrative claims-based proxies.
The main objective of this study is the development of algorithms/models to predict eGFR
values and/or classes for patients at certain time point based on entries in claims database
(demographic characteristics, clinical diagnoses, procedures and drug treatments) for a
general population and a variety of use-cases (atrial fibrillation, coronary artery disease,
type 2 diabetes mellitus patients sub-populations). To achieve this, modern data-driven
machine learning techniques will be applied to discover relationships between renal status,
measured by eGFR, and longitudinal patient-level data.
Evaluation of models' performance (out of sample validation, benchmark test, performance
differences between eGFR value prediction algorithms and classification models tailored for
the pre-defined eGFR classes) will be done as well.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01217736 -
Direct Renin Inhibition and the Kidney
|
Phase 1 | |
| Completed |
NCT04742816 -
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients
|
Phase 4 | |
| Completed |
NCT01598987 -
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
|
Phase 3 | |
| Completed |
NCT00992043 -
Creatine Supplementation and Diabetes
|
N/A | |
| Recruiting |
NCT04334135 -
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
|
N/A | |
| Completed |
NCT04940260 -
Soluble Factors and Renal Outcome in Preeclampsia
|
||
| Recruiting |
NCT02288663 -
Renal Function Assessment in the Elderly Using Plasma Creatinine Assay and Lean Body Mass Measurement
|
N/A | |
| Completed |
NCT01227213 -
The Vascular and Metabolic Effects of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
|
N/A | |
| Completed |
NCT03228563 -
The Effect of Probiotics on Chronic Kidney Disease
|
N/A | |
| Completed |
NCT01680744 -
The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup
|
N/A | |
| Completed |
NCT05179564 -
Renal Function Assessment in Critically Ill Children
|
N/A | |
| Recruiting |
NCT05503147 -
Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)
|
Phase 1 | |
| Not yet recruiting |
NCT05813730 -
Urinary Creatinine Excretion Time in the Neonatal Period
|
N/A | |
| Withdrawn |
NCT01802255 -
Sevoflurane- Safety in Long-term Sedation Procedures
|
Phase 3 | |
| Completed |
NCT01320722 -
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
|
N/A | |
| Completed |
NCT01925235 -
Analysis of Remote-ischemic Preconditioning Effects on Kidney Function
|
N/A | |
| Completed |
NCT01138241 -
Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
|
||
| Completed |
NCT00634920 -
Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
|
Phase 4 | |
| Recruiting |
NCT03170739 -
Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery
|
Phase 4 | |
| Completed |
NCT00117390 -
Evaluation of the Optimal Technique for Determination of Renal Function of Critically Ill Patients
|
N/A |